Cambridge Investment Research Advisors’s Monogram Orthopaedics MGRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,621
Closed -$92K 3909
2025
Q3
$92K Sell
15,621
-4,048
-21% -$21.6K ﹤0.01% 3596
2025
Q2
$57K Buy
+19,669
New +$53K ﹤0.01% 3530

Cambridge Investment Research Advisors's MGRM Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 15,621 shares — an estimated $92K sold.

Cambridge Investment Research Advisors first reported a position in MGRM in Q2 2025 and held it in 2 quarters. The position peaked at $92K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,621 Monogram Orthopaedics shares in Q4 2025, an estimated $92K.
  • Cambridge Investment Research Advisors first reported a position in Monogram Orthopaedics in Q2 2025 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Monogram Orthopaedics position peaked at $92K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.